Review History


All reviews of published articles are made public. This includes manuscript files, peer review comments, author rebuttals and revised materials. Note: This was optional for articles submitted before 13 February 2023.

Peer reviewers are encouraged (but not required) to provide their names to the authors when submitting their peer review. If they agree to provide their name, then their personal profile page will reflect a public acknowledgment that they performed a review (even if the article is rejected). If the article is accepted, then reviewers who provided their name will be associated with the article itself.

View examples of open peer review.

Summary

  • The initial submission of this article was received on September 3rd, 2020 and was peer-reviewed by 3 reviewers and the Academic Editor.
  • The Academic Editor made their initial decision on November 2nd, 2020.
  • The first revision was submitted on November 14th, 2020 and was reviewed by 2 reviewers and the Academic Editor.
  • The article was Accepted by the Academic Editor on November 27th, 2020.

Version 0.2 (accepted)

· Nov 27, 2020 · Academic Editor

Accept

The authors have addressed the questions that the reviewers raised in the first edition. The quality of the manuscript has been improved in the current version.

Reviewer 1 ·

Basic reporting

No comment

Experimental design

No comment

Validity of the findings

No comment

Additional comments

The authors have addressed the questions that I raised in the first edition. The quality of the manuscript has been improved in the current version.

Reviewer 3 ·

Basic reporting

no comments

Experimental design

no comments

Validity of the findings

no comments

Version 0.1 (original submission)

· Nov 2, 2020 · Academic Editor

Minor Revisions

The authors mentioned there was rare data to describe decades’ long natural history or changes of a cancer and liver cancer. For the last decades when we compared the survival rates in drug studies including the real-life experiences we could easily find out the differences in cancer mortality of liver cancer. The results are predictable even for an epidemic area.

Abstract section of manuscript must be re-wriitten.

[# PeerJ Staff Note: Please ensure that all review comments are addressed in a rebuttal letter and any edits or clarifications mentioned in the letter are also inserted into the revised manuscript where appropriate. It is a common mistake to address reviewer questions in the rebuttal letter but not in the revised manuscript. If a reviewer raised a question then your readers will probably have the same question so you should ensure that the manuscript can stand alone without the rebuttal letter. Directions on how to prepare a rebuttal letter can be found at: https://peerj.com/benefits/academic-rebuttal-letters/ #]

Reviewer 1 ·

Basic reporting

English language is clear and well-written throughout the manuscript. However, there are some minor points that need to be revised:

Line 57: Add reference
Line 261: Revise ‘these different patterns’

Experimental design

Line 152: Why did you select 35-64 as the threshold?
Line 153: What about people that are elder than 74-year-old?

Validity of the findings

Line 226: Please briefly explain the population structure changes over the decades

Additional comments

This study summarized the changes in liver cancer mortality rates over the decades in Qidong. The authors also highlighted the possibility that the change in aflatoxin intake may contribute to the decrease of liver cancer mortality rate.

Reviewer 2 ·

Basic reporting

Professional English throughout
Sufficient literature references
There are many mortality terms in the manuscript and they can be defined more clearly

Experimental design

It is a really original primary research. To tell you the truth, I haven't read an article that investigated such long-term cancer mortality in an epidemic area.
However research question in not well defined and meaningful. Because the result are predictable.

Validity of the findings

Conclusions are well stated and linked to original research question.
However, there is no impact and novelty in the manuscript.

Additional comments

No comment

Reviewer 3 ·

Basic reporting

I appreciate authors for putting great deal of effort into this study that details of Liver Cancer Mortality trends. This study details analyzing data coming from two different sources- one being retrospective death survey data and another being cancer registry data. Study data spans over few decades. Authors have used various metrics such as natural death rate, cancer mortality rate, liver cancer mortality rate in this study to look at trends over many years.

This is well done study with many data points and have certain limitations in terms of presentation.

• As a reviewer, I suggest re writing and rephrasing entire abstract to make more sense. In current structure it is tough to comprehend. Since this manuscript aimed at reaching to wide range of international audience it would be better to have abstract with better sentences.
• As a reviewer when I looked at the abstract and at the rest of the manuscript, there is a clear difference of English between both. I suggest reframing and restructuring sentences in abstract.
• Abstract is repeated twice this manuscript.

• In methods of abstract it should be age standardized rate instead of age stand ardized rate

• In results section of the abstract, the natural death rate percentage symbol should be "%"

• Authors might want to think if this is appropriate way of representing cancer mortality rate in results section of the abstract. I feel it is not in sync with what is detailed in manuscript. In the body of the manuscript it is represented as 10 to the power of 5 but here in abstract it is represented as 105 at five instances.


• At line 99- I understand that ICD-10 system is the latest. Appropriate references to showcase ICD-10 implementation date in China would be helpful. In United States ICD 10 system has not been implemented until later of 2010.

Experimental design

• From line 77-93 in methods I would also suggest how details to include if the data analyzed was deidentified or identified or how the deidentification was done.

• Authors might also add few details about which software was used for data analysis and running the statistics in methods section.

Validity of the findings

no comments

Additional comments

no comments

All text and materials provided via this peer-review history page are made available under a Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.